ADC Therapeutics SA Weighted Average Shares
ADC Therapeutics SA (ADCT) reported Weighted Average Shares of 82.26 million shares for the 3-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2023-11-07
- ADC Therapeutics SA weighted average shares for the quarter ending 2023-09-30 was 82.26M shares, a 4.96% increase year-over-year.
- ADC Therapeutics SA weighted average shares for the quarter ending 2023-06-30 was 81.47M shares, a 5.93% increase year-over-year.
- ADC Therapeutics SA weighted average shares for the quarter ending 2023-03-31 was 80.81M shares, a 5.19% increase year-over-year.
- ADC Therapeutics SA weighted average shares for the quarter ending 2022-09-30 was 78.37M shares, a 2.13% increase year-over-year.
| Period end | Weighted Average Shares 3 month | Weighted Average Shares 6 month | Weighted Average Shares 9 month | Weighted Average Shares 12 month |
|---|---|---|---|---|
| 2023-09-30 | 82.26M shares 6-K · filed 2023-11-07 | 81.52M shares 6-K · filed 2023-11-07 | ||
| 2023-06-30 | 81.47M shares 6-K · filed 2023-08-08 | 81.14M shares 6-K · filed 2023-08-08 | ||
| 2023-03-31 | 80.81M shares 6-K · filed 2023-05-09 | |||
| 2022-12-31 | 78.15M shares 20-F · filed 2023-03-15 | |||
| 2022-09-30 | 78.37M shares 6-K · filed 2023-11-07 | 77.37M shares 6-K · filed 2023-11-07 | ||
| 2022-06-30 | 76.91M shares 6-K · filed 2023-08-08 | 76.87M shares 6-K · filed 2023-08-08 | ||
| 2022-03-31 | 76.82M shares 6-K · filed 2023-05-09 | |||
| 2021-12-31 | 76.75M shares 20-F · filed 2023-03-15 | |||
| 2021-09-30 | 76.74M shares 6-K · filed 2022-11-08 | 76.73M shares 6-K · filed 2022-11-08 | ||
| 2021-06-30 | 76.73M shares 6-K · filed 2022-08-09 | 76.73M shares 6-K · filed 2022-08-09 | ||
| 2021-03-31 | 76.72M shares 6-K · filed 2022-05-09 | |||
| 2020-12-31 | 65.41M shares 20-F · filed 2023-03-15 | |||
| 2020-09-30 | 70.91M shares 6-K · filed 2021-11-02 | 61.61M shares 6-K · filed 2021-11-02 | ||
| 2020-06-30 | 62.86M shares 6-K · filed 2021-08-03 | 57.23M shares 6-K · filed 2021-08-03 | ||
| 2020-03-31 | 50.96M shares 6-K · filed 2021-05-06 | |||
| 2019-12-31 | 49.28M shares 20-F · filed 2022-03-17 | |||
| 2018-12-31 | 46.60M shares 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |